Can primaquine therapy for vivax malaria be improved?

Can primaquine therapy for vivax malaria be improved?

The incidence and range of endemic malaria caused by Plasmodium vivax has expanded during the past 30 years. This parasite forms hypnozoites in the liver, creating a persistent reservoir of infection. Primaquine (PQ), introduced 50 years ago, is the only drug available to eliminate hypnozoites. Howe...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Baird, J, Rieckmann, K
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2003

Eitemau Tebyg

Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
gan: Baird, J
Cyhoeddwyd: (2018)

Primaquine as anti-relapse therapy for Plasmodium vivax
gan: Baird, J
Cyhoeddwyd: (1998)

Primaquine therapy for malaria.
gan: Baird, J, et al.
Cyhoeddwyd: (2004)

High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
gan: Krudsood, S, et al.
Cyhoeddwyd: (2008)

Treatment of primaquine-resistant Plasmodium vivax malaria.
gan: Luzzi, G, et al.
Cyhoeddwyd: (1992)

TREATMENT OF PRIMAQUINE-RESISTANT PLASMODIUM-VIVAX MALARIA
gan: Luzzi, G, et al.
Cyhoeddwyd: (1992)

Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria.
gan: Fryauff, D, et al.
Cyhoeddwyd: (1995)

Primaquine for plasmodium vivax malaria treatment – authors' reply
gan: Price, RN, et al.
Cyhoeddwyd: (2020)

Primaquine in vivax malaria: an update and review on management issues
gan: Fernando Deepika, et al.
Cyhoeddwyd: (2011-12-01)

Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis
gan: Pavani Reddy, et al.
Cyhoeddwyd: (2006-11-01)

Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
gan: Sutanto, I, et al.
Cyhoeddwyd: (2013)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
gan: Walter R J Taylor, et al.
Cyhoeddwyd: (2021-09-01)

Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria
gan: Watson, J, et al.
Cyhoeddwyd: (2019)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria
gan: Taylor, WRJ, et al.
Cyhoeddwyd: (2021)

Reinventing primaquine for endemic malaria.
gan: Baird, J
Cyhoeddwyd: (2012)

Therapeutic Responses of Plasmodium vivax Malaria to Chloroquine and Primaquine Treatment in Northeastern Myanmar.
gan: Yuan, L, et al.
Cyhoeddwyd: (2014)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
gan: Setyadi, A, et al.
Cyhoeddwyd: (2019)

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
gan: Llanos-Cuentas, A, et al.
Cyhoeddwyd: (2019)

Consideration of ethics in primaquine therapy against malaria transmission.
gan: Baird, J, et al.
Cyhoeddwyd: (2011)

Consideration of ethics in primaquine therapy against malaria transmission
gan: Baird, J, et al.
Cyhoeddwyd: (2011)

Higher-dose primaquine to prevent relapse of Plasmodium vivax malaria
gan: Watson, JA, et al.
Cyhoeddwyd: (2022)

Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria.
gan: Pukrittayakamee, S, et al.
Cyhoeddwyd: (1994)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
gan: Agus Setyadi, et al.
Cyhoeddwyd: (2019-04-01)

Artesdiaquine and Primaquine combined treatment is more effective for Malaria vivax
gan: Santoso Santoso
Cyhoeddwyd: (2012-07-01)

Primaquine for prevention of malaria in travelers.
gan: Baird, J, et al.
Cyhoeddwyd: (2003)

Genetic Analysis of Primaquine Tolerance in a Patient with Relapsing Vivax Malaria
gan: A. Taylor Bright, et al.
Cyhoeddwyd: (2013-05-01)

Rational malaria chemoprophylaxis - the position of primaquine
gan: Baird, J
Cyhoeddwyd: (2017)

Determinants of primaquine and carboxyprimaquine exposures in children and adults with Plasmodium vivax malaria
gan: Chu, CS, et al.
Cyhoeddwyd: (2021)

Mass primaquine treatment to eliminate vivax malaria: Lessons from the past
gan: Kondrashin, A, et al.
Cyhoeddwyd: (2014)

Genetic analysis of primaquine tolerance in a patient with relapsing vivax malaria.
gan: Bright, A, et al.
Cyhoeddwyd: (2013)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
gan: Baird, J, et al.
Cyhoeddwyd: (2018)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
gan: James Watson, et al.
Cyhoeddwyd: (2018-04-01)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
gan: Watson, J, et al.
Cyhoeddwyd: (2018)

Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in plasmodium vivax malaria
gan: Chu, C, et al.
Cyhoeddwyd: (2018)

Comparison of the umulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in Plasmodium vivax malaria
gan: Chu, C, et al.
Cyhoeddwyd: (2018)

Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.
gan: Baird, J, et al.
Cyhoeddwyd: (1995)

Absence of gender influence on the pharmacokinetics of chloroquine combined with primaquine in malaria vivax patients
gan: Michelle Valeria Dias Ferreira Vieira, et al.
Cyhoeddwyd: (2020-10-01)

Levels of primaquine and carboxyprimaquine in patients with malaria vivax from the Brazilian Amazon basin
gan: Amanda Gabryelle Nunes Cardoso Mello, et al.
Cyhoeddwyd: (2018-10-01)

Therapeutic efficacy of chloroquine and primaquine for <it>Plasmodium vivax</it> malaria treatment in southeast Iran
gan: Heidari Aliehsan, et al.
Cyhoeddwyd: (2012-10-01)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
gan: Taylor, WR, et al.
Cyhoeddwyd: (2021)